EQS-News: Andera Partners Portfolio Company Mineralys Therapeutics Successfully Completes Upsized $192 Million Nasdaq IPO
PARIS, FRANCE – FEBRUARY 14, 2023 – Andera Partners, a leading European private equity player, through its practice Andera Life Sciences, focused on investments in companies developing breakthrough therapeutics and medical technologies, announces that its portfolio company Mineralys Therapeutics completed last Friday an oversubscribed and upsized $192 million initial public offering (IPO) on the Nasdaq Global Select Market at $16.00 per share.